Login / Signup

Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.

Nicolas ClementyBruno GarciaClémentine AndréArnaud BissonNazih BenhendaBertrand PierreAnne BernardLaurent FauchierEric PiverDominique Babuty
Published in: PloS one (2018)
Galectin-3 levels independently predict outcomes in patients with reduced left ventricular systolic function addressed for ablation of persistent AF, and may be of interest in defining the therapeutic strategy in this population.
Keyphrases